<DOC>
	<DOCNO>NCT01599650</DOCNO>
	<brief_summary>This study generate comparative data 0.5-mg ranibizumab use PRN dosing administer without adjunctive laser treatment versus laser photocoagulation ( current standard care ) Month 6 patient visual impairment due ME secondary BRVO . Additionally result study provide long-term ( 24-month ) safety efficacy data ranibizumab , administer without adjunctive laser treatment indication .</brief_summary>
	<brief_title>Efficacy Safety Ranibizumab With Without Laser Comparison Laser Branch Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Vision Disorders</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Written informed consent must obtain study assessment perform Diagnosis visual impairment exclusively due ME secondary BRVO BCVA score Screening Baseline 73 19 letter ( ETDRS ) Pregnant nursing ( lactate ) woman Stroke myocardial infarction le 3 month Screening Uncontrolled blood pressure define systolic value &gt; 160 mm Hg diastolic value &gt; 100 mm Hg Screening Baseline . Any active periocular ocular infection inflammation Screening Baseline either eye Uncontrolled glaucoma Screening Baseline diagnose within 6 month Baseline either eye Neovascularization iris neovascular glaucoma study eye Use systemic antivascular endothelial growth factor ( antiVEGF ) drug within 6 month Baseline Panretinal laser photocoagulation within 3 month Baseline anticipate schedule within next 3 month follow Baseline study eye Focal grid laser photocoagulation within 4 month Baseline study eye Use intra periocular corticosteroid ( include subTenon ) within 3 month Screening study eye Any use intraocular corticosteroid implant ( eg , dexamethasone [ Ozurdex® ] , fluocinolone acetonide [ Iluvien® ] ) study eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Macular Edema , Branch Retinal Vein Occlusion , visual impairment</keyword>
</DOC>